The Rally from 544 lows to 653 highs looks choppy to upside & corrective in nature-holding 600-605 zone as important support zone -if starts moving above 605 we shall look for 620-624 as next upside target & crossing above 624 - we shall look for 645 - 665 - 710 - Holding 700 & above we shall look for 730-740 zone.
Getting a chance later in the zone 605-607 as interim support can be an opportunity for next up move in repeated fashion. Note - No buying trades below 605
27th April 2018 Looking for a slip below 624-620 to 600-605 zone giving us 15-20 odd points & holding 600-605 zone -expect a bounce.
--------------------------------------------------------------------------------------------------------------------------------------------- New to TradingView - Look for TradingView India - Intro Video in Youtube ---------------------------------------------------------------------------------------------------------------------------------------------
Auropharma - All Related Analysis of Auropharma has been put in sequence below. Fall from 895 to 500 & Interim Analysis has been put for reference.
Trade active
13:52 Hrs 7th May 2018
Last Price@624
On 624 ---------------that was lovely move from the bottoms of 600-605.
Trade active
13:56 Hrs 7th May 2018
Last Price@622
Holding 624-625 zone upside - we shall look for 615-617 zone next & below 615 for 610 & 605-607 as interim targets. Any support in 615-617 zone can be opportunity to push upside for 624-645 later.
Thanks
Trade active
14:13 Hrs 7th May 2018
Last Price@622.50
Recent High@624.75
Turning down from 624-625 could be nothing less than a miracle.
Trade active
14:41 Hrs 7th May 2018
Last Price@621.50
Do not hold your position above 625 which is key level upside. Crossing 625 -obviously -you should avoid taking sell positions. We got 2-3 times opportunity to sell in 624-625 zone indicating that 625 is important level.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.